Evidence map›Paper›PMID 37111374›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications.

Nuria Vilaboa, Juan Antonio Lopez, Marco de Mesa, Clara Escudero-Duch, Natalie Winfield, Melanie Bayford, Richard Voellmy

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Withaferin A and Celastrol Overwhelm Proteostasis.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nuria VilaboaHospital Universitario La Paz-IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0003-4473-4498
Juan Antonio LopezCentro Nacional de Investigaciones Cardiovasculares, CNIC, 28029 Madrid, Spain.ORCID 0000-0002-9097-6060
Marco de MesaHospital Universitario La Paz-IdiPAZ, 28046 Madrid, Spain.
Clara Escudero-DuchHospital Universitario La Paz-IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0002-5617-0995
Natalie WinfieldDomainex Ltd., Chesterford Research Park, Little Chesterford, Essex, Saffron Walden CB10 1XL, UK.
Melanie BayfordDomainex Ltd., Chesterford Research Park, Little Chesterford, Essex, Saffron Walden CB10 1XL, UK.
Richard VoellmyHSF Pharmaceuticals SA, 1814 La Tour-de-Peilz, Switzerland.ORCID 0000-0003-4183-0871

Funding

EPIDEMIOLOGY OF DRUG USE PATTERNS AMONG WOMENR29DA007406 · NIDA · GEORGIA STATE UNIVERSITY · PI STERK, CLAIRE E · 1992 to 1994
–
Comunidad de Madrid P2022/BMD-7406Comunidad de Madrid Program I2HSF Pharmaceuticals SA HSF Pharmaceuticals SAMinisterio de Ciencia e Innovación, Spain PID2021-126325OB-I00Ministerio de Ciencia e Innovación, Spain RED2018-102626-TMinisterio de Ciencia e Innovación, Spain RTI2018-095159-B-I00
6 · The paper itself

Abstract

Exposure of many cancer cells, including multiple myeloma cells, to cytotoxic concentrations of natural products celastrol and withaferin A or synthetic compounds of the IHSF series resulted in denaturation of a luciferase reporter protein. Proteomic analysis of detergent-insoluble extract fractions from HeLa-derived cells revealed that withaferin A, IHSF058 and IHSF115 caused denaturation of 915, 722 and 991 of 5132 detected cellular proteins, respectively, of which 440 were targeted by all three compounds. Western blots showed that important fractions of these proteins, in some cases approaching half of total protein amounts, unfolded. Relatively indiscriminate covalent modification of target proteins was observed; 1178 different proteins were modified by IHSF058. Further illustrating the depth of the induced proteostasis crisis, only 13% of these proteins detectably aggregated, and 79% of the proteins that aggregated were not targets of covalent modification. Numerous proteostasis network components were modified and/or found in aggregates. Proteostasis disruption caused by the study compounds may be more profound than that mediated by proteasome inhibitors. The compounds act by a different mechanism that may be less susceptible to resistance development. Multiple myeloma cells were particularly sensitive to the compounds. Development of an additional proteostasis-disrupting therapy of multiple myeloma is suggested.

Indexed as

celastrolIHSFmultiple myeloma 1protein aggregationprotein unfoldingproteostasis disruptionproteostasis inhibitionwithaferin A

Identifiers

PMID37111374
PMCPMC10145903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.